EXUMA Biotech Corp.

CIK 1698021 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for EXUMA Biotech Corp..

Recent SEC filings

FiledFormAccession number
Aug 20, 2026D0001698021-26-000003
Apr 21, 2020D0001567619-20-008219
Feb 23, 2017D0001698021-17-000001